What to Expect from Alexandria Real Estate's Earnings
Alexandria Real Estate (NYSE:ARE) is gearing up to announce its quarterly earnings on Monday, 2026-01-26. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Alexandria Real Estate will report an earnings per share (EPS) of $1.04.
Investors in Alexandria Real Estate are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Earnings History Snapshot
Last quarter the company beat EPS by $1.06, which was followed by a 19.17% drop in the share price the next day.
Here's a look at Alexandria Real Estate's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 1.16 | 1.30 | 2.28 | 2.39 |
| EPS Actual | 2.22 | 2.33 | 2.30 | 2.39 |
| Price Change % | -19.00 | 3.00 | -6.00 | -5.00 |

Performance of Alexandria Real Estate Shares
Shares of Alexandria Real Estate were trading at $58.09 as of January 22. Over the last 52-week period, shares are down 42.89%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
Analyst Opinions on Alexandria Real Estate
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Alexandria Real Estate.
Alexandria Real Estate has received a total of 12 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $60.92, the consensus suggests a potential 4.87% upside.
Analyzing Ratings Among Peers
In this comparison, we explore the analyst ratings and average 1-year price targets of American Healthcare REIT, CareTrust REIT and Healthpeak Properties, three prominent industry players, offering insights into their relative performance expectations and market positioning.
- Analysts currently favor an Outperform trajectory for American Healthcare REIT, with an average 1-year price target of $54.67, suggesting a potential 5.89% downside.
- Analysts currently favor an Outperform trajectory for CareTrust REIT, with an average 1-year price target of $42.12, suggesting a potential 27.49% downside.
- Analysts currently favor an Neutral trajectory for Healthpeak Properties, with an average 1-year price target of $18.8, suggesting a potential 67.64% downside.
Key Findings: Peer Analysis Summary
In the peer analysis summary, key metrics for American Healthcare REIT, CareTrust REIT and Healthpeak Properties are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.
| Company | Consensus | Revenue Growth | Gross Profit | Return on Equity |
|---|---|---|---|---|
| Alexandria Real Estate | Neutral | -5.14% | $496.62M | -1.39% |
| American Healthcare REIT | Outperform | 9.38% | $118.41M | 2.19% |
| CareTrust REIT | Outperform | 82.43% | $101.66M | 2.05% |
| Healthpeak Properties | Neutral | 0.78% | $413.95M | -1.51% |
Key Takeaway:
Alexandria Real Estate ranks at the bottom for Revenue Growth and Gross Profit, while it is in the middle for Return on Equity. Its Consensus rating is neutral. The peers show a mix of performance, with one outperforming in all metrics, one outperforming in two metrics, and another having mixed results.
All You Need to Know About Alexandria Real Estate
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.
A Deep Dive into Alexandria Real Estate's Financials
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Challenges: Alexandria Real Estate's revenue growth over 3 months faced difficulties. As of 30 September, 2025, the company experienced a decline of approximately -5.14%. This indicates a decrease in top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Alexandria Real Estate's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -31.93%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Alexandria Real Estate's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -1.39%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Alexandria Real Estate's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.63%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.84, Alexandria Real Estate adopts a prudent financial strategy, indicating a balanced approach to debt management.
To track all earnings releases for Alexandria Real Estate visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.


